Tufts

Using an immunoassay as an initial screening tool saved approximately $36,000 over multiplex PCR panel use alone when performed in a period of high flu prevalence.

The device consists of a reservoir that enables the analyte to contact only the top of a screen-printed electrode, increasing sensitivity.

Researchers at Tufts and their collaborators recently demonstrated that the approach, which uses multiphoton microscopy, can distinguish between normal and cancerous skin.